evista

Generic: raloxifene hydrochloride

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name evista
Generic Name raloxifene hydrochloride
Labeler eli lilly and company
Dosage Form TABLET
Routes
ORAL
Active Ingredients

raloxifene hydrochloride 60 mg/1

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-4184
Product ID 0002-4184_d46edd04-2907-438c-9e1f-b94b5509c0fd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020815
Listing Expiration 2026-12-31
Marketing Start 1998-01-06

Pharmacologic Class

Classes
estrogen agonist/antagonist [epc] selective estrogen receptor modulators [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00024184
Hyphenated Format 0002-4184

Supplemental Identifiers

RxCUI
1490065 1490067
UPC
0300024184305
UNII
4F86W47BR6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name evista (source: ndc)
Generic Name raloxifene hydrochloride (source: ndc)
Application Number NDA020815 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (0002-4184-30)
source: ndc

Packages (1)

Ingredients (1)

raloxifene hydrochloride (60 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d46edd04-2907-438c-9e1f-b94b5509c0fd", "openfda": {"upc": ["0300024184305"], "unii": ["4F86W47BR6"], "rxcui": ["1490065", "1490067"], "spl_set_id": ["fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0002-4184-30)", "package_ndc": "0002-4184-30", "marketing_start_date": "20161216"}], "brand_name": "Evista", "product_id": "0002-4184_d46edd04-2907-438c-9e1f-b94b5509c0fd", "dosage_form": "TABLET", "pharm_class": ["Estrogen Agonist/Antagonist [EPC]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "0002-4184", "generic_name": "Raloxifene hydrochloride", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Evista", "active_ingredients": [{"name": "RALOXIFENE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "NDA020815", "marketing_category": "NDA", "marketing_start_date": "19980106", "listing_expiration_date": "20261231"}